 | • レポートコード：QYR2104Z4119 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、次世代がん診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（次世代シーケンシング、qPCR＆マルチプレックス、DNAマイクロアレイ、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・次世代がん診断の市場動向 ・企業の競争状況、市場シェア ・次世代がん診断の種類別市場規模（次世代シーケンシング、qPCR＆マルチプレックス、DNAマイクロアレイ、その他） ・次世代がん診断の用途別市場規模（病院、診療所、その他） ・次世代がん診断の北米市場規模2016-2027（アメリカ、カナダ） ・次世代がん診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・次世代がん診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・次世代がん診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・次世代がん診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Cepheid、Koninklijke Philips N.V、F. Hoffmann-La Roche Ltd、Qiagen、Novartis AG、Abbott、Thermo Fisher Scientific、Opko Health、Myriad Genetics、Agilent Technologies、GE Healthcare、PerkinElmer、Genomic Health、Illumina、Hologic、Almac Group、Janssen Global Services、Sysmex Corporation） ・結論 |
Market Analysis and Insights: Global Next Generation Cancer Diagnostics Market
The global Next Generation Cancer Diagnostics market size is projected to reach US$ 17680 million by 2026, from US$ 5351.3 million in 2019, at a CAGR of 18.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Cancer Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Cancer Diagnostics market.
Global Next Generation Cancer Diagnostics Scope and Market Size
Next Generation Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Qiagen
Novartis AG
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 DNA Microarrays
1.2.5 Other
1.3 Market by Application
1.3.1 Global Next Generation Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Cancer Diagnostics Market Perspective (2016-2027)
2.2 Next Generation Cancer Diagnostics Growth Trends by Regions
2.2.1 Next Generation Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Next Generation Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Next Generation Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Next Generation Cancer Diagnostics Industry Dynamic
2.3.1 Next Generation Cancer Diagnostics Market Trends
2.3.2 Next Generation Cancer Diagnostics Market Drivers
2.3.3 Next Generation Cancer Diagnostics Market Challenges
2.3.4 Next Generation Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Cancer Diagnostics Players by Revenue
3.1.1 Global Top Next Generation Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Next Generation Cancer Diagnostics Revenue
3.4 Global Next Generation Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Next Generation Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostics Revenue in 2020
3.5 Next Generation Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Next Generation Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Next Generation Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Cancer Diagnostics Breakdown Data by Type
4.1 Global Next Generation Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2022-2027)
5 Next Generation Cancer Diagnostics Breakdown Data by Application
5.1 Global Next Generation Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Next Generation Cancer Diagnostics Market Size (2016-2027)
6.2 North America Next Generation Cancer Diagnostics Market Size by Type
6.2.1 North America Next Generation Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Next Generation Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Next Generation Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America Next Generation Cancer Diagnostics Market Size by Application
6.3.1 North America Next Generation Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Next Generation Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Next Generation Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America Next Generation Cancer Diagnostics Market Size by Country
6.4.1 North America Next Generation Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Next Generation Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Next Generation Cancer Diagnostics Market Size (2016-2027)
7.2 Europe Next Generation Cancer Diagnostics Market Size by Type
7.2.1 Europe Next Generation Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Next Generation Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Next Generation Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe Next Generation Cancer Diagnostics Market Size by Application
7.3.1 Europe Next Generation Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Next Generation Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Next Generation Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe Next Generation Cancer Diagnostics Market Size by Country
7.4.1 Europe Next Generation Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Next Generation Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Next Generation Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America Next Generation Cancer Diagnostics Market Size by Type
9.2.1 Latin America Next Generation Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Next Generation Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Next Generation Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Next Generation Cancer Diagnostics Market Size by Application
9.3.1 Latin America Next Generation Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Next Generation Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Next Generation Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Next Generation Cancer Diagnostics Market Size by Country
9.4.1 Latin America Next Generation Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Next Generation Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cepheid
11.1.1 Cepheid Company Details
11.1.2 Cepheid Business Overview
11.1.3 Cepheid Next Generation Cancer Diagnostics Introduction
11.1.4 Cepheid Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.1.5 Cepheid Recent Development
11.2 Koninklijke Philips N.V
11.2.1 Koninklijke Philips N.V Company Details
11.2.2 Koninklijke Philips N.V Business Overview
11.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Introduction
11.2.4 Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.2.5 Koninklijke Philips N.V Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Next Generation Cancer Diagnostics Introduction
11.4.4 Qiagen Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.4.5 Qiagen Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Next Generation Cancer Diagnostics Introduction
11.5.4 Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Next Generation Cancer Diagnostics Introduction
11.6.4 Abbott Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Introduction
11.7.4 Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Opko Health
11.8.1 Opko Health Company Details
11.8.2 Opko Health Business Overview
11.8.3 Opko Health Next Generation Cancer Diagnostics Introduction
11.8.4 Opko Health Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.8.5 Opko Health Recent Development
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Details
11.9.2 Myriad Genetics Business Overview
11.9.3 Myriad Genetics Next Generation Cancer Diagnostics Introduction
11.9.4 Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.9.5 Myriad Genetics Recent Development
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Details
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Next Generation Cancer Diagnostics Introduction
11.10.4 Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.10.5 Agilent Technologies Recent Development
11.11 GE Healthcare
11.11.1 GE Healthcare Company Details
11.11.2 GE Healthcare Business Overview
11.11.3 GE Healthcare Next Generation Cancer Diagnostics Introduction
11.11.4 GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.11.5 GE Healthcare Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Details
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Next Generation Cancer Diagnostics Introduction
11.12.4 PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.12.5 PerkinElmer Recent Development
11.13 Genomic Health
11.13.1 Genomic Health Company Details
11.13.2 Genomic Health Business Overview
11.13.3 Genomic Health Next Generation Cancer Diagnostics Introduction
11.13.4 Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.13.5 Genomic Health Recent Development
11.14 Illumina
11.14.1 Illumina Company Details
11.14.2 Illumina Business Overview
11.14.3 Illumina Next Generation Cancer Diagnostics Introduction
11.14.4 Illumina Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.14.5 Illumina Recent Development
11.15 Hologic
11.15.1 Hologic Company Details
11.15.2 Hologic Business Overview
11.15.3 Hologic Next Generation Cancer Diagnostics Introduction
11.15.4 Hologic Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.15.5 Hologic Recent Development
11.16 Almac Group
11.16.1 Almac Group Company Details
11.16.2 Almac Group Business Overview
11.16.3 Almac Group Next Generation Cancer Diagnostics Introduction
11.16.4 Almac Group Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.16.5 Almac Group Recent Development
11.17 Janssen Global Services
11.17.1 Janssen Global Services Company Details
11.17.2 Janssen Global Services Business Overview
11.17.3 Janssen Global Services Next Generation Cancer Diagnostics Introduction
11.17.4 Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.17.5 Janssen Global Services Recent Development
11.18 Sysmex Corporation
11.18.1 Sysmex Corporation Company Details
11.18.2 Sysmex Corporation Business Overview
11.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Introduction
11.18.4 Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2016-2021)
11.18.5 Sysmex Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Next Generation Sequencing
Table 3. Key Players of qPCR & Multiplexing
Table 4. Key Players of DNA Microarrays
Table 5. Key Players of Other
Table 6. Global Next Generation Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Next Generation Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Next Generation Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Next Generation Cancer Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Next Generation Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Next Generation Cancer Diagnostics Market Share by Regions (2022-2027)
Table 12. Next Generation Cancer Diagnostics Market Trends
Table 13. Next Generation Cancer Diagnostics Market Drivers
Table 14. Next Generation Cancer Diagnostics Market Challenges
Table 15. Next Generation Cancer Diagnostics Market Restraints
Table 16. Global Next Generation Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Next Generation Cancer Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Next Generation Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostics as of 2020)
Table 19. Ranking of Global Top Next Generation Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Next Generation Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Next Generation Cancer Diagnostics Product Solution and Service
Table 23. Date of Enter into Next Generation Cancer Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Next Generation Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Next Generation Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Next Generation Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Next Generation Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Next Generation Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Next Generation Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Next Generation Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Next Generation Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Next Generation Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Next Generation Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Next Generation Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Next Generation Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Next Generation Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Next Generation Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Next Generation Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Next Generation Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Next Generation Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Next Generation Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Next Generation Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Next Generation Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Next Generation Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Cepheid Company Details
Table 64. Cepheid Business Overview
Table 65. Cepheid Next Generation Cancer Diagnostics Product
Table 66. Cepheid Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Cepheid Recent Development
Table 68. Koninklijke Philips N.V Company Details
Table 69. Koninklijke Philips N.V Business Overview
Table 70. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product
Table 71. Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Koninklijke Philips N.V Recent Development
Table 73. F. Hoffmann-La Roche Ltd Company Details
Table 74. F. Hoffmann-La Roche Ltd Business Overview
Table 75. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product
Table 76. F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 77. F. Hoffmann-La Roche Ltd Recent Development
Table 78. Qiagen Company Details
Table 79. Qiagen Business Overview
Table 80. Qiagen Next Generation Cancer Diagnostics Product
Table 81. Qiagen Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Qiagen Recent Development
Table 83. Novartis AG Company Details
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Next Generation Cancer Diagnostics Product
Table 86. Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Novartis AG Recent Development
Table 88. Abbott Company Details
Table 89. Abbott Business Overview
Table 90. Abbott Next Generation Cancer Diagnostics Product
Table 91. Abbott Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Thermo Fisher Scientific Company Details
Table 94. Thermo Fisher Scientific Business Overview
Table 95. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product
Table 96. Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Thermo Fisher Scientific Recent Development
Table 98. Opko Health Company Details
Table 99. Opko Health Business Overview
Table 100. Opko Health Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Opko Health Recent Development
Table 102. Myriad Genetics Company Details
Table 103. Myriad Genetics Business Overview
Table 104. Myriad Genetics Next Generation Cancer Diagnostics Product
Table 105. Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Myriad Genetics Recent Development
Table 107. Agilent Technologies Company Details
Table 108. Agilent Technologies Business Overview
Table 109. Agilent Technologies Next Generation Cancer Diagnostics Product
Table 110. Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Agilent Technologies Recent Development
Table 112. GE Healthcare Company Details
Table 113. GE Healthcare Business Overview
Table 114. GE Healthcare Next Generation Cancer Diagnostics Product
Table 115. GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 116. GE Healthcare Recent Development
Table 117. PerkinElmer Company Details
Table 118. PerkinElmer Business Overview
Table 119. PerkinElmer Next Generation Cancer Diagnostics Product
Table 120. PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 121. PerkinElmer Recent Development
Table 122. Genomic Health Company Details
Table 123. Genomic Health Business Overview
Table 124. Genomic Health Next Generation Cancer Diagnostics Product
Table 125. Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 126. Genomic Health Recent Development
Table 127. Illumina Company Details
Table 128. Illumina Business Overview
Table 129. Illumina Next Generation Cancer Diagnostics Product
Table 130. Illumina Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 131. Illumina Recent Development
Table 132. Hologic Company Details
Table 133. Hologic Business Overview
Table 134. Hologic Next Generation Cancer Diagnostics Product
Table 135. Hologic Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 136. Hologic Recent Development
Table 137. Almac Group Company Details
Table 138. Almac Group Business Overview
Table 139. Almac Group Next Generation Cancer Diagnostics Product
Table 140. Almac Group Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 141. Almac Group Recent Development
Table 142. Janssen Global Services Company Details
Table 143. Janssen Global Services Business Overview
Table 144. Janssen Global Services Next Generation Cancer Diagnostics Product
Table 145. Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 146. Janssen Global Services Recent Development
Table 147. Sysmex Corporation Company Details
Table 148. Sysmex Corporation Business Overview
Table 149. Sysmex Corporation Next Generation Cancer Diagnostics Product
Table 150. Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 151. Sysmex Corporation Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Next Generation Sequencing Features
Figure 3. qPCR & Multiplexing Features
Figure 4. DNA Microarrays Features
Figure 5. Other Features
Figure 6. Global Next Generation Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Next Generation Cancer Diagnostics Report Years Considered
Figure 11. Global Next Generation Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Next Generation Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Next Generation Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Next Generation Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Next Generation Cancer Diagnostics Market Share by Players in 2020
Figure 16. Global Top Next Generation Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Next Generation Cancer Diagnostics Revenue in 2020
Figure 18. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Next Generation Cancer Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Next Generation Cancer Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Next Generation Cancer Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Next Generation Cancer Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Next Generation Cancer Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Next Generation Cancer Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Next Generation Cancer Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Next Generation Cancer Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Next Generation Cancer Diagnostics Market Share by Region (2016-2027)
Figure 40. China Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Next Generation Cancer Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Next Generation Cancer Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Next Generation Cancer Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Next Generation Cancer Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Next Generation Cancer Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Next Generation Cancer Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Next Generation Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Cepheid Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 60. Koninklijke Philips N.V Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 62. Qiagen Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 66. Opko Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 67. Myriad Genetics Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 68. Agilent Technologies Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 69. GE Healthcare Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 70. PerkinElmer Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 71. Genomic Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 72. Illumina Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 73. Hologic Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 74. Almac Group Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 75. Janssen Global Services Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 76. Sysmex Corporation Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の次世代乳がん診断＆スクリーニング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Next-Generation Breast Cancer Diagnostic and Screening Market The global Next-Generation Breast Cancer Diagnostic and Screening market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry…- 世界の第3世代シーケンス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Third-Generation Sequencing Market The global Third-Generation Sequencing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の臨床腫瘍学次世代シーケンシング（NGS）市場規模・現状・予測（2021年-2027年） NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations. The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence…
- 世界の次世代シーケンシング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Next-Generation Sequencing Market The global Next-Generation Sequencing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の次世代シーケンシング情報市場規模・現状・予測（2021年-2027年） Next-Generation Sequencing Informatics, also known as High-throughput sequencing, is marked by the ability to sequence one hundred thousand to one million DNA molecules in parallel, often with short readings. Market Analysis and Insights: Global Next-Generation Sequencing Informatics Market The glob…